Ra Pharmaceuticals, Inc.
Q3 2018 vs. Q1 2020 13F Holders
Period
Q3 2018
Q1 2020
Num holders
73
168
Total reported value, excl. options
$445 M
$2.47 B
Total shares, excl. options
24,615,215
51,427,536
Compare Q1 2020 to
2020 Q2
2019 Q4
2019 Q3
2019 Q2
2019 Q1
2018 Q4
2018 Q3
2018 Q2
2018 Q1
2017 Q4
2017 Q3
2017 Q2
2017 Q1
2016 Q4
Manager
Q3 2018
Shares
Q1 2020
Shares
Diff
Chg %